Related Experiment Video
Updated: Jun 10, 2025

06:24
Author Spotlight: Advancements in iPSCs and Genetic Disease Research
Published on: October 20, 2023
1.0K
Alternative Ways to Obtain Human Mesenchymal Stem Cells from Embryonic Stem Cells
Nikita Onyanov1, Olga Glazova2,3, Nawar Sakr2
1Moscow Center for Advanced Studies, Kulakova Str. 20, Moscow 123592, Russia.
Cells
|October 15, 2024
Summary
Xeno-free media better support mesenchymal stem cell (MSC) characteristics like morphology and growth. However, serum-containing media enhance MSC differentiation potential for bone, cartilage, and fat lineages.
Area of Science:
- Stem cell biology
- Cell differentiation
- Regenerative medicine
Background:
- Mesenchymal stem cells (MSCs) are crucial for regenerative medicine.
- Existing differentiation protocols yield varied MSC types, hindering research.
- Standardizing MSC differentiation is essential for therapeutic applications.
Purpose of the Study:
- To compare three differentiation methods for obtaining MSCs from embryonic stem cells (ESCs).
- To evaluate the impact of serum-containing versus xeno-free media on MSC characteristics.
- To assess the multilineage differentiation potential of MSCs derived from different protocols.
Main Methods:
- Differentiating ESCs from early mesoderm into MSCs using three distinct protocols.
- Utilizing both serum-containing and xeno-free differentiation media.
- Analyzing cell morphology, doubling rate, colony formation, surface markers, and multilineage potential.
Main Results:
- Xeno-free medium yielded MSCs with optimal morphology, growth kinetics, and surface marker profiles.
- Serum-containing medium demonstrated superior potential for osteogenic, chondrogenic, and adipogenic differentiation.
- Differences in cell morphology, proliferation, and surface markers were observed across protocols.
Conclusions:
- Xeno-free media are preferable for defining MSC characteristics and identity.
- Serum-containing media support robust multilineage differentiation capacity.
- Protocol selection depends on the intended application of derived MSCs.
Related Concept Videos
Embryonic Stem Cells
3.4K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
3.4K
Mesenchymal Stem Cells
4.6K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K

